JP Morgan Healthcare Conference, Day Four: Affymetrix, Bio-Rad | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up today with a handful of life science tools and molecular diagnostics companies presenting to investors.

Affymetrix

Earlier this week Affymetrix announced a restructuring aimed at returning the firm to profitability and revenue growth. That restructuring included an 8 percent workforce reduction, or 100 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.